๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide

โœ Scribed by Hiroki Sakamoto; Masayuki Kitano; Takamitsu Komaki; Kazu Noda; Takaaki Chikugo; Masatoshi Kudo

Publisher
Springer Japan
Year
2009
Tongue
English
Weight
318 KB
Volume
44
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Paclitaxel, carboplatin, and extended sc
Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma
โœ John D. Hainsworth; Steven L. Stroup; F. Anthony Greco ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 577 KB

## BACKGROUND. Paclitaxel is an active agent in the initial treatment of patients with small cell lung carcinoma. The authors evaluated the toxicity and efficacy of paclitaxel (1-hour infusion) added to a standard combination regimen of carboplatin and etoposide in a Phase I1 trial for the treatme

Small cell undifferentiated bronchogenic
Small cell undifferentiated bronchogenic carcinoma: Current status with emphasis upon the role of chemotherapy
โœ Paul S. Johnson; John F. Foley; Anne Kessinger; Henry M. Lemon ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 568 KB

## Abstract Current opinions concerning tumor biology and clinical characteristics of small cell undifferentiated bronchogenic carcinoma are reviewed. Special emphasis is placed upon chemotherapy for this lung cancer subtype and presently achievable response rates and survival times are presented.